Literature DB >> 2998178

Computed tomography assisted volumetric analysis of primary liver tumor as a measure of response to therapy.

D S Ettinger, P K Leichner, S S Siegelman, E K Fishman, J L Klein, S E Order.   

Abstract

Serial computed tomography assisted volumetric analyses were made in 33 patients with hepatoma. Thirteen of 27 patients with tumor volumes less than 2,290 cc had a partial response to experimental therapy. However, only three of these patients also demonstrated a significant change in liver volume. Tumor volume determinations made by the method described are an accurate (+/- 10%) and reproducible way to measure response to therapy. In spite of small changes in total liver volume, there may be concomitantly substantial changes in tumor volume.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2998178     DOI: 10.1097/00000421-198510000-00014

Source DB:  PubMed          Journal:  Am J Clin Oncol        ISSN: 0277-3732            Impact factor:   2.339


  4 in total

1.  Papillary-cystic neoplasm of the pancreas with multiple hepatic metastases: a case report.

Authors:  Y Matsuda; Y Imai; S Kawata; M Nishikawa; S Miyoshi; R Saito; Y Minami; S Tarui
Journal:  Gastroenterol Jpn       Date:  1987-06

2.  Antipyrine clearance per unit liver volume in cirrhotics with and without hepatocellular carcinoma indicating a correlation with histological change of the liver.

Authors:  S Noda; S Kawata; S Miyoshi; Y Minami; S Tarui
Journal:  Gastroenterol Jpn       Date:  1989-04

3.  CT volume measurement for prognostic evaluation of unresectable hepatocellular carcinoma after TACE.

Authors:  Jia-Wen Zhang; Xiao-Yuan Feng; Han-Qiu Liu; Zhen-Wei Yao; Yan-Mei Yang; Bin Liu; Yong-Qiang Yu
Journal:  World J Gastroenterol       Date:  2010-04-28       Impact factor: 5.742

4.  Theranostic oxygen delivery using ultrasound and microbubbles.

Authors:  James J Kwan; Mehmet Kaya; Mark A Borden; Paul A Dayton
Journal:  Theranostics       Date:  2012-12-23       Impact factor: 11.556

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.